• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桔梗皂苷D通过激活河马信号通路的LATS2/YAP1轴赋予结直肠癌对奥沙利铂的抗性。

Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway.

作者信息

Wang Chien-Hao, Baskaran Rathinasamy, Ng Shawn Shang-Chuan, Wang Tso-Fu, Li Chi-Cheng, Ho Tsung-Jung, Hsieh Dennis Jine-Yuan, Kuo Chia-Hua, Chen Ming-Cheng, Huang Chih-Yang

机构信息

Department of Chinese Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien, Taiwan.

Integration Center of Traditional Chinese and Modern Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

出版信息

J Cancer. 2023 Jan 22;14(3):393-402. doi: 10.7150/jca.77322. eCollection 2023.

DOI:10.7150/jca.77322
PMID:36860929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9969589/
Abstract

Oxaliplatin-based therapy is used as a first-line drug to treat metastatic colorectal cancer. However, long-term and repeated drug treatment resulted in drug resistance and the failure of chemotherapy. Various natural compounds were previously reported to act as chemosensitizers to reverse drug resistance. In this study, we found that platycodin D (PD), a saponin found in , inhibited LoVo and OR-LoVo cells proliferation, invasion, and migration ability. Our results indicated that combined treatment of oxaliplatin with PD dramatically reduced the cellular proliferation in both LoVo and OR-LoVo cells. Furthermore, treatment with PD dose-dependently decreased LATS2/YAP1 hippo signaling and survival marker p-AKT expression, as well as increased cyclin-dependent kinase inhibitor proteins such as p21 and p27 expression. Importantly, PD activates and promotes YAP1 degradation through the ubiquitination and proteasome pathway. The nuclear transactivation of YAP was significantly reduced under PD treatment, leading to transcriptional inhibition of the downstream genes regulating cell proliferation, pro-survival, and metastasis. In conclusion, our results showed that PD is suitable as a promising agent for overcoming oxaliplatin-resistant colorectal cancer.

摘要

基于奥沙利铂的疗法被用作治疗转移性结直肠癌的一线药物。然而,长期和重复的药物治疗导致了耐药性和化疗失败。先前有报道称,各种天然化合物可作为化学增敏剂来逆转耐药性。在本研究中,我们发现桔梗皂苷D(PD),一种存在于……中的皂苷,抑制了LoVo和OR-LoVo细胞的增殖、侵袭和迁移能力。我们的结果表明,奥沙利铂与PD联合治疗显著降低了LoVo和OR-LoVo细胞中的细胞增殖。此外,PD处理剂量依赖性地降低了LATS2/YAP1河马信号通路和存活标志物p-AKT的表达,同时增加了细胞周期蛋白依赖性激酶抑制剂蛋白如p21和p27的表达。重要的是,PD通过泛素化和蛋白酶体途径激活并促进YAP1的降解。在PD处理下,YAP的核转激活显著降低,导致对调节细胞增殖、促存活和转移的下游基因的转录抑制。总之,我们的结果表明,PD适合作为一种有前景的药物来克服奥沙利铂耐药的结直肠癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/7e946491141d/jcav14p0393g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/2fca208b97ee/jcav14p0393g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/0b4107339a5a/jcav14p0393g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/07fbc283c973/jcav14p0393g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/3aa817bb75ed/jcav14p0393g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/521777b58f07/jcav14p0393g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/c7df8472504f/jcav14p0393g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/64f4bf2419e1/jcav14p0393g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/7e946491141d/jcav14p0393g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/2fca208b97ee/jcav14p0393g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/0b4107339a5a/jcav14p0393g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/07fbc283c973/jcav14p0393g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/3aa817bb75ed/jcav14p0393g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/521777b58f07/jcav14p0393g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/c7df8472504f/jcav14p0393g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/64f4bf2419e1/jcav14p0393g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/9969589/7e946491141d/jcav14p0393g008.jpg

相似文献

1
Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway.桔梗皂苷D通过激活河马信号通路的LATS2/YAP1轴赋予结直肠癌对奥沙利铂的抗性。
J Cancer. 2023 Jan 22;14(3):393-402. doi: 10.7150/jca.77322. eCollection 2023.
2
Platycodin D sensitizes -mutant colorectal cancer cells to cetuximab by inhibiting the PI3K/Akt signaling pathway.桔梗皂苷D通过抑制PI3K/Akt信号通路使KRAS突变型结直肠癌细胞对西妥昔单抗敏感。
Front Oncol. 2022 Oct 27;12:1046143. doi: 10.3389/fonc.2022.1046143. eCollection 2022.
3
RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.RASAL2 通过 hippo 信号通路的 LATS2/YAP1 轴促进结直肠癌的肿瘤进展。
Mol Cancer. 2018 Jul 23;17(1):102. doi: 10.1186/s12943-018-0853-6.
4
FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer.FOXC1对miR-31-5p的调控通过靶向LATS2赋予结直肠癌对奥沙利铂的抗性。
Cancers (Basel). 2019 Oct 16;11(10):1576. doi: 10.3390/cancers11101576.
5
Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling.肌球蛋白轻链 9 通过与 Yes 相关蛋白 1 结合并调节 Hippo 信号通路促进结直肠癌细胞的增殖、侵袭、迁移和血管生成。
Bioengineered. 2022 Jan;13(1):96-106. doi: 10.1080/21655979.2021.2008641.
6
Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.桔梗皂苷 D 通过抑制 EGFR 介导的 Akt 和 MAPK 通路抑制 MDA-MB-231 人乳腺癌细胞的迁移、侵袭和生长。
Chem Biol Interact. 2013 Oct 5;205(3):212-21. doi: 10.1016/j.cbi.2013.07.002. Epub 2013 Jul 16.
7
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.微小RNA-103a-3p通过河马/Yes相关蛋白1/缺氧诱导因子1α轴促进结直肠癌的肿瘤糖酵解。
J Exp Clin Cancer Res. 2020 Nov 20;39(1):250. doi: 10.1186/s13046-020-01705-9.
8
Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.雌二醇激动剂通过p53抑制人LoVo结肠癌细胞的增殖和迁移。
World J Gastroenterol. 2014 Nov 28;20(44):16665-73. doi: 10.3748/wjg.v20.i44.16665.
9
Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.熊果酸和阿霉素通过靶向 Akt 信号通路和激活 Hippo 信号通路抑制结直肠肿瘤发生。
Mol Med Rep. 2023 Jan;27(1). doi: 10.3892/mmr.2022.12898. Epub 2022 Nov 16.
10
The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.Hippo 激酶 LATS2 控制幽门螺杆菌诱导的胃黏膜上皮-间充质转化和肠化生。
Cell Mol Gastroenterol Hepatol. 2020;9(2):257-276. doi: 10.1016/j.jcmgh.2019.10.007. Epub 2019 Oct 24.

引用本文的文献

1
Hippo/YAP signaling pathway in colorectal cancer: regulatory mechanisms and potential drug exploration.结直肠癌中的Hippo/YAP信号通路:调控机制与潜在药物探索
Front Oncol. 2025 Jun 19;15:1545952. doi: 10.3389/fonc.2025.1545952. eCollection 2025.
2
Plant Terpenoids in Combination with Conventional Therapeutics in Colorectal Cancer: A Promising Option.植物萜类化合物与传统疗法联合用于结直肠癌:一种有前景的选择。
Curr Oncol Rep. 2025 Apr 21. doi: 10.1007/s11912-025-01674-2.
3
Molecular mechanisms of Hippo pathway in tumorigenesis: therapeutic implications.

本文引用的文献

1
Mechanisms of YAP/TAZ transcriptional control.YAP/TAZ转录调控机制。
Cell Stress. 2021 Oct 29;5(11):167-172. doi: 10.15698/cst2021.11.258. eCollection 2021 Nov.
2
An updated review on pharmacological properties of neferine-A bisbenzylisoquinoline alkaloid from Nelumbo nucifera.从荷花中提取的双苄基异喹啉生物碱荷叶碱的药理学特性的最新综述。
J Food Biochem. 2021 Dec;45(12):e13986. doi: 10.1111/jfbc.13986. Epub 2021 Nov 14.
3
Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.
Hippo信号通路在肿瘤发生中的分子机制:治疗意义
Mol Biol Rep. 2025 Feb 27;52(1):267. doi: 10.1007/s11033-025-10372-y.
4
An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.一种用于评估热灌注腹腔化疗对结直肠癌治疗效果的类器官模型
Ann Surg Oncol. 2025 Mar;32(3):1925-1940. doi: 10.1245/s10434-024-16469-1. Epub 2024 Nov 26.
5
Targeted Treatment against Cancer Stem Cells in Colorectal Cancer.针对结直肠癌中的癌症干细胞的靶向治疗。
Int J Mol Sci. 2024 Jun 5;25(11):6220. doi: 10.3390/ijms25116220.
6
Nomogram model including expression was constructed to predict the prognosis of advanced gastric cancer after surgery.构建了包含表达的列线图模型,以预测进展期胃癌术后的预后。
World J Gastrointest Surg. 2024 Feb 27;16(2):518-528. doi: 10.4240/wjgs.v16.i2.518.
7
Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer.天然药物化合物靶向信号转导通路,以克服 ABC 药物外排转运体介导的癌症多药耐药性。
Drug Resist Updat. 2023 Nov;71:101004. doi: 10.1016/j.drup.2023.101004. Epub 2023 Aug 21.
8
Tumor-targeted liposomes with platycodin D2 promote apoptosis in colorectal cancer.携带桔梗皂苷D2的肿瘤靶向脂质体可促进结直肠癌细胞凋亡。
Mater Today Bio. 2023 Jul 29;22:100745. doi: 10.1016/j.mtbio.2023.100745. eCollection 2023 Oct.
化疗和放疗耐药的分子机制及其对癌症治疗的潜在影响。
MedComm (2020). 2021 Jun 10;2(3):315-340. doi: 10.1002/mco2.55. eCollection 2021 Sep.
4
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities.新视角下癌细胞中紫杉醇和多西紫杉醇耐药性的发展:EMT 作为一种新的分子机制和治疗可能性。
Biomed Pharmacother. 2021 Sep;141:111824. doi: 10.1016/j.biopha.2021.111824. Epub 2021 Jun 25.
5
Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer.Hippo 通路:癌症中的调控、失调及潜在治疗靶点。
Cancer Lett. 2021 Jun 1;507:112-123. doi: 10.1016/j.canlet.2021.03.006. Epub 2021 Mar 15.
6
The Hippo Signaling Pathway in Drug Resistance in Cancer.癌症耐药中的河马信号通路
Cancers (Basel). 2021 Jan 16;13(2):318. doi: 10.3390/cancers13020318.
7
Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation.远志糖苷 D 通过抑制 ERK1/2 介导的原肌球蛋白-1 磷酸化逆转肝癌细胞中组蛋白去乙酰化酶抑制剂耐药性。
Phytomedicine. 2021 Feb;82:153442. doi: 10.1016/j.phymed.2020.153442. Epub 2020 Dec 23.
8
YAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes.YAP/TAZ信号通路在结直肠癌中的作用:基于共识分子亚型的经验教训
Cancers (Basel). 2020 Oct 28;12(11):3160. doi: 10.3390/cancers12113160.
9
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer. Hippo 秀必须继续:YAP 激活作为结直肠癌的治疗策略。
Cell Stem Cell. 2020 Oct 1;27(4):501-502. doi: 10.1016/j.stem.2020.09.007.
10
YAP promotes epithelial mesenchymal transition by upregulating Slug expression in human colorectal cancer cells.YAP通过上调人结肠癌细胞中Slug的表达来促进上皮-间质转化。
Int J Clin Exp Pathol. 2020 Apr 1;13(4):701-710. eCollection 2020.